HARROW, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: 615.733.4731
CIK: 0001360214
EIN: 450567010
State Location: TN
State of Inc.: DE
Tickers:
  • Nasdaq:HROW
  • Nasdaq:HROWL
  • Nasdaq:HROWM

Form: SCHEDULE 13G

Filing Date: 11 Mar 2026
Report Date:
Accepted: 11 Mar 2026 12:50 p.m.
Accession Number: 0001099910-26-000101
Act: 34
File Number: 005-83793
Film Number: 26742873

Documents

Primary Document
Accepted: 11 Mar 2026 12:50 p.m.